Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any acute myeloid leukemia that has the chromosomal anomaly RUNX1 gene mutation. (A change in the nucleotide sequence of the RUNX1 gene.)
Biomarker and diagnostic research for acute myeloid leukemia, RUNX1 gene mutation has been reported in the published literature.
No clinical trials have been registered for acute myeloid leukemia, RUNX1 gene mutation.
156 publications have been identified in PubMed for acute myeloid leukemia, RUNX1 gene mutation. Kisho has analyzed 55 by research type. Research spans Basic Science / Preclinical (42%), Diagnostic / Biomarker (18%), and Epidemiology / Natural History (16%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 23 | 42% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 1:01 AM UTC
Common questions about acute myeloid leukemia, RUNX1 gene mutation
Testing and diagnosis research |
10 |
18% |
Disease patterns and progression | 9 | 16% |
Research summaries | 7 | 13% |
Patient case studies | 2 | 4% |
Clinical study results | 2 | 4% |
Other research | 1 | 2% |
New treatment approaches | 1 | 2% |
Wang D (2026). [PMID: 42087483](https://pubmed.ncbi.nlm.nih.gov/42087483/). *Cancer Med*. [Epidemiology / Natural History]
Kannan N (2026). [PMID: 41819800](https://pubmed.ncbi.nlm.nih.gov/41819800/). *J Clin Pathol*. [Basic Science / Preclinical]
Dhir A (2026). [PMID: 41214140](https://pubmed.ncbi.nlm.nih.gov/41214140/). *Leukemia*. [Basic Science / Preclinical]
Batayneh O (2026). [PMID: 41514668](https://pubmed.ncbi.nlm.nih.gov/41514668/). *Cancers (Basel)*. [Basic Science / Preclinical]
Bill M (2026). [PMID: 41145671](https://pubmed.ncbi.nlm.nih.gov/41145671/). *Leukemia*. [Diagnostic / Biomarker]
Chang YS (2026). [PMID: 41742883](https://pubmed.ncbi.nlm.nih.gov/41742883/). *Haematologica*. [Diagnostic / Biomarker]
Zhang L (2026). [PMID: 41797681](https://pubmed.ncbi.nlm.nih.gov/41797681/). *Ann Med*. [Diagnostic / Biomarker]
Mecklenbrauck R (2026). [PMID: 41663622](https://pubmed.ncbi.nlm.nih.gov/41663622/). *Leukemia*. [Diagnostic / Biomarker]
de Cássia Cavaglieri R (2026). [PMID: 42031658](https://pubmed.ncbi.nlm.nih.gov/42031658/). *Clin Lymphoma Myeloma Leuk*. [Review / Meta-Analysis]
Shi S (2025). [PMID: 40020451](https://pubmed.ncbi.nlm.nih.gov/40020451/). *Leuk Res*. [Basic Science / Preclinical]